
HFMD cases in Sabah under control, says Health Dept
KOTA KINABALU: The rise in hand, foot and mouth disease (HFMD) cases in Sabah remains under control due to swift action and ongoing preventive measures carried out across the state, says Dr Maria Suleiman.
The Sabah Health director said a total of 6,919 HFMD cases had been reported as of May 10 this year.
'Although there has been an increase in HFMD cases, the situation is under control. Nevertheless, with the control measures and precautions we have implemented, the HFMD situation in Sabah is under control and the number of cases is on the decline,' Dr Maria said.
She was speaking after attending the 2025 state-level Nurses' Day celebration and blood donation programme at the main lobby of Queen Elizabeth II Hospital here on Tuesday (May 13).
The event was officiated by Chief Minister Datuk Seri Hajiji Noor, who was represented by Deputy Chief Minister Datuk Shahelmey Yahya.
Dr Maria also shared that they aim to collect 1,000 pints of blood statewide as part of the Nurses' Day celebration.
'So far, Queen Elizabeth II Hospital has collected 52 pints of blood out of the daily target of 100,' she said.
Meanwhile, Hajiji, in his speech, urged more programmes to be implemented to raise awareness on the importance of donating blood.
'I have been informed that the daily blood requirement for Sabah is 300 units and each year, we need about 110,000 to 120,000 units to meet patients' needs. However, to date, only 75,000 units are collected each year,' he said.
Hajiji said collaboration between the Health Ministry and the public sector can raise awareness on blood donation and to attract the public to become regular donors, adding: 'Indeed, voluntary blood donation helps save patients' lives.'
He said since the quality of the healthcare system heavily relies on the quality of the nursing workforce, investment in training, welfare, and career development for nurses is crucial to ensure the sustainability of the country's healthcare system.
'In this regard, the State Government always appreciates and supports nurses serving in Sabah who sacrifice their time and energy for the health of the people. I hope all nurses will continue to strive to improve the quality of healthcare services, particularly in this state,' he said.
The Chief Minister also paid tribute to nurses, whom he said are the backbone of the nation's healthcare system.
'The Nurses' Day celebrations is not just a symbolic event but a significant recognition of the group that serves as the backbone of the nation's healthcare system, our nurses.
'In line with this year's theme, 'Our Nurses, Our Future: Caring for Nurses Strengthens the Economy', the role of nurses extends beyond just being 'patient caregivers' in hospitals, they are also catalysts for community well-being, health educators, and frontline workers in managing health crises,' he said.
The Chief Minister recalled the extraordinary role of nurses during the Covid-19 pandemic a few years back, not only in terms of treatment and monitoring but also in providing emotional and moral support to patients and their families.
"Some had to be separated from their families, spouses, and children in order to fulfil their responsibilities at that time.
"Indeed, they are unsung heroes who remain strong, resilient and steadfast working under various challenging situations, whether in wards, emergency units, rural health clinics, or disaster areas," he said.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Malaysian Reserve
an hour ago
- Malaysian Reserve
GSK invests $300,000 to help launch the Pharmacy Innovation in Immunization Research Collaborative (PIIRC) at the University of Waterloo School of Pharmacy
PIIRC serves as a catalyst for innovation by supporting interdisciplinary research and real-world evidence generation focused on improving vaccine access, delivery and education. MISSISSAUGA, ON, June 6, 2025 /CNW/ – GSK is proud to announce a $300,000 investment in the Pharmacy Innovation in Immunization Research Collaborative (PIIRC), a new national initiative led by the School of Pharmacy at the University of Waterloo. This groundbreaking initiative reflects a shared commitment to expanding the role of pharmacy in Canada's immunization landscape and improving equitable access to vaccines across the country. Immunization has never been more critical. The COVID-19 pandemic underscored the life-saving power of vaccines and demonstrated the essential role that pharmacists and pharmacies play in public health. Pharmacy teams have administered more than 20 million COVID-19 vaccines in Canada alone. Yet, there remains untapped potential to leverage the country's 11,000+ pharmacies as accessible, community-based hubs for broader immunization services. PIIRC aims to close that gap. Launched by the largest clinical pharmacy practice research group in Canada, PIIRC serves as a catalyst for innovation by supporting interdisciplinary research and real-world evidence generation focused on improving vaccine access, delivery and education. The initiative brings together researchers from the University of Waterloo, national and international collaborators, policymakers and stakeholders across healthcare and industry to advance pharmacy-based immunization strategies. 'As a global leader in vaccines, we believe in harnessing science and partnerships to tackle the world's most pressing health challenges,' said Michelle Horn, Country Medical Director, GSK Canada. 'Through our founding partnership with PIIRC, we are investing not only in research, but in the future of vaccine delivery in Canada—one that is more accessible, equitable, and community-centred.' Transforming Immunization Through Pharmacy Innovation The objective of PIIRC is to re-imagine the role of pharmacy in immunization—from vaccine administration to health education, monitoring, and system design. Areas of research will include: Expanding the role of pharmacists and pharmacy technicians as vaccine educators, facilitators, and immunizers Overcoming barriers to access, especially among rural residents, older adults, immunocompromised individuals, and other underserved populations Leveraging digital health tools and technology to support clinical decision-making and personalized outreach Countering vaccine misinformation through evidence-based communication strategies and resources for healthcare providers Conducting economic analyses to examine the cost-effectiveness and public health value of pharmacy-based vaccine services Implementing science methodologies to ensure successful and scalable solutions across regions and populations This work will be supported by the School's extensive expertise in pharmacy practice research, health systems design, health economics, public policy, behavioural science, and communication strategies. 'As a leader in clinical pharmacy practice research and community pharmacy innovation, the University of Waterloo's School of Pharmacy continues to push boundaries,' said Andrea Edginton, Hallman Director, School of Pharmacy at the University of Waterloo. 'PIIRC is a natural evolution of our work in immunization, and GSK's partnership will accelerate breakthroughs that improve public health both in Canada and globally.' Impact Beyond the Lab In addition to funding innovative research, GSK's investment will also: Provide funding to support new interdisciplinary projects with direct policy and practice implications Train the next generation of immunization researchers, including PharmD students, graduate students and postdoctoral fellows Facilitate enhanced access to real-world pharmacy data to monitor vaccine uptake and identify areas for intervention Establish a network of community pharmacies engaged in research, data collection and pilot projects Enable regular knowledge translation activities to ensure research is informed by and disseminated to industry, government and community stakeholders Support the creation of an Advisory Board that includes voices from pharmaceutical and insurance companies, regulators, pharmacy associations and the public Strategic Alignment with Public Health and Policy This investment directly supports the Ontario Life Sciences Strategy by demonstrating private sector leadership in supporting community-based immunization services. By investing in evidence that shows how pharmacy can help achieve broader public health goals—including for future vaccine program rollouts such as RSV—GSK is playing a critical role in advancing both healthcare outcomes and policy development. 'Our support for PIIRC is not just about generating data; it's about making a meaningful contribution to the future of healthcare,' added Michelle Horn, Country Medical Director, GSK Canada. 'We're proud to stand alongside the University of Waterloo School of Pharmacy in driving innovative, patient-centred immunization strategies that reflect our mission to get ahead of disease together and our commitment to doing what's right for communities and for public health.' Why Waterloo and Why Now? The University of Waterloo's collaborative ethos, track record of external partnerships and commitment to impact make it an ideal home for PIIRC. The University creates substantial opportunities for high-impact partnerships that bridge the gap between research and application. PIIRC helps shape policy and guides decision-making with timely, actionable evidence that reflects the realities of patients, pharmacists and public health professionals. GSK's early and decisive investment solidifies its reputation as a forward-thinking leader in the pharmacy space and a partner of choice in advancing vaccine innovation. About the University of Waterloo School of PharmacyThe School of Pharmacy at the University of Waterloo is home to Canada's largest clinical pharmacy practice research group and is at the forefront of pharmacy innovation. Through interdisciplinary research and industry collaboration, the School is advancing pharmacy's role in improving health systems and patient outcomes. About GSK GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. Find out more at Cautionary statement regarding forward-looking statements GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described in the 'Risk Factors' section in GSK's Annual Report on Form 20-F for 2024, and GSK's Q1 Results for 2025.


New Straits Times
2 hours ago
- New Straits Times
No intervention means Gaza genocide continues
RIGHTS groups, lawyers and some governments are describing the Gaza war as "genocide" and calling for a ceasefire but Israel, created in the aftermath of the Nazi Holocaust of Jews, vehemently rejects the explosive term. Israel's military offensive on Gaza since October 2023 has killed 54,677 people, mostly civilians, according to the Health Ministry in the occupied Palestinian territory. The United Nations has said the territory's entire population of more than two million people is at risk of famine, even if Israel said last month it was partially easing the complete blockade on aid it imposed on Gaza on March 2. Despite international calls for an end to the war, a ceasefire agreement between Israel and Hamas remains elusive. In December 2023, South Africa brought a case to the International Court of Justice (ICJ), the United Nations' highest judicial organ, alleging that Israel's Gaza offensive breached the 1948 UN Convention on the Prevention and Punishment of the Crime of Genocide. In rulings in January, March and May 2024, the ICJ told Israel to do everything possible to "prevent" acts of genocide during its military operations in Gaza, including by providing urgently needed humanitarian aid to prevent famine. Amnesty International has accused Israel of carrying out a "live-streamed genocide" in Gaza, while Human Rights Watch has alleged it is responsible for "acts of genocide". A UN committee in November found Israel's warfare in Gaza was "consistent with the characteristics of genocide". And a UN investigation concluded in March that Israel carried out "genocidal acts" in Gaza through the destruction of the strip's main IVF (in vitro fertilisation) clinic and other reproductive healthcare facilities. Omer Bartov, an Israeli scholar of the Holocaust, wrote in August last year that "Israel was engaged in systematic war crimes, crimes against humanity and genocidal actions". Fellow Israeli historians Amos Goldberg and Daniel Blatman in January co-wrote an article in which they said: "Israel is indeed committing genocide in Gaza." France's President Emmanuel Macron has said it is not up to a "political leader to use the term but up to historians to do so when the time comes". But Turkish President Recep Tayyip Erdogan has used it and Brazilian President Luiz Inacio Lula da Silva has accused Israel of "premeditated genocide". The International Criminal Court (ICC) in November issued arrest warrants for Israeli Prime Minister Benjamin Netanyahu and former defence minister Yoav Gallant over alleged crimes against humanity and war crimes in Israel's war in Gaza — including starvation as a method of warfare. In the case of Rwanda, in which the UN said extremist Hutus killed some 800,000 Tutsis and moderate Hutus in 1994, it took a decade for the International Criminal Tribunal to conclude genocide had happened. It was not until 2007 that the ICJ recognised as genocide the murder by Bosnian Serb forces of almost 8,000 Muslim men and boys in Srebrenica in 1995 during the Bosnian war. French-Israeli lawyer Omer Shatz said "there is no doubt that war crimes, crimes against humanity are being committed" in Gaza. But the international law expert agreed intent was more difficult to prove. That is why, after the ICC issued an arrest warrant against Netanyahu and Gallant, Shatz filed a report with the court in December arguing they were among eight Israeli officials responsible for "incitement to genocide in Gaza". "If incitement is established, that establishes intent," he said. His 170-page report lists such alleged incitements, including Gallant at the start of the war saying Israel was fighting "human animals" in Gaza and far-right Finance Minister Bezalel Smotrich urging "total extermination" in the Palestinian territory. Mathilde Philip-Gay, an international law expert, warned: "International law cannot stop a war. The judiciary will intervene after the war. "The qualification (of genocide) is very important for victims but it will come later." The 1948 Genocide Convention says signatories can call on UN organs "to take such action... for the prevention and suppression of acts of genocide".


Focus Malaysia
5 hours ago
- Focus Malaysia
Surge in HFMD cases in Malaysia: Key facts and prevention tips
AMID the excitement of school holidays, parents and caregivers should remain extra cautious as the recent surge in Hand, Foot, and Mouth Disease (HFMD) cases reported nationwide underscores the importance of remaining vigilant of the warning signs associated with the illness. Though it is common during this time of the year, Sunway Medical Centre, Sunway City (SMC) paediatric infectious disease consultant Dr Ch'ng Tong Wei said that the current scale of transmission is alarming, necessitating heightened awareness and preventive measures. 'As a paediatric infectious disease specialist, I have observed a rise in hospital referrals, concerned parental inquiries, and requests for guidance from preschools and kindergartens on outbreak management,' she said. Understanding HFMD HFMD is a highly contagious viral infection predominantly affecting children under five. The illness typically presents with: Fever Sore throat Reduced appetite Painful oral ulcers Rash on the hands, feet, and occasionally buttocks Most cases are mild, with recovery within 7–10 days. However, a small number of cases, usually linked to EV71 virus strain, may lead to complications such as: Viral meningitis Encephalitis (brain inflammation) Cardiopulmonary complications. The good news is that these complications remain very rare, she said. Current outbreak situation According to the Health Ministry, HFMD cases throughout sees a 266% increase in infections compared to the same period last year. The number of HFMD cases in Malaysia has risen to 99,601 as of the 17th epidemiological week this year, compared to 27,236 cases during the same period last year. No fatalities were reported linked to the disease. The ministry said 10,421 cases this year or 10% were outbreak-related, while 90% or 89,180 cases occurred sporadically. Prevention tips for parents and schools 'Since there is no specific treatment for HFMD, prevention and comfort care are essential,' she said. The measures to be taken into consideration are: Keep sick children at home Children with HFMD should remain at home until all blisters have dried and they are fever-free for at least 24 hours. This is the most effective way to stop the virus from spreading. Hand-washing is critical. Practice good hygiene Teach children to wash their hands thoroughly with soap, especially after using the toilet and before eating. Disinfect toys and surfaces regularly with chlorine-based or antiviral disinfectants. Avoid high-risk areas during outbreaks Temporarily limit visits to playgrounds, childcare centres, or crowded spaces during outbreaks where transmissions are more likely. Avoid sharing utensils, towels, or personal items. Provide comfort care for infected children Offer soft foods, cool drinks, and administer paracetamol if needed for fever or pain. Seeking medical attention According to Dr Ch'ng, most children recover without complications, but consulting a doctor is paramount if the child exhibits symptoms such as: Refusal to eat or drink (risk of dehydration) High fever (above 39°C) lasting more than 2 days Lethargy, irritability, or altered consciousness Severe cases may require hospitalisation for intravenous hydration, antipyretics, and close neurological monitoring, she added. Curbing HFMD outbreak is a shared responsibility The recent rise in cases across Selangor, Johor, Perak, and other states is a reminder that we must remain vigilant—not just in hospitals, but as a community. We are monitoring the situation closely with its paediatric teams, nurses, and infection control unit are working hand-in-hand to support parents and manage cases safely and efficiently. By staying informed and adopting preventive measures, Dr Ch'ng believes we can collectively reduce transmission and safeguard our children's health. 'Together, we can protect our children and reduce transmission by adhering to the guidelines. For further inquiries or medical advice, please consult a healthcare professional,' she added. ‒ June 4, 2025 Main image: Ovum Hospitals